Bone marrow immunohistochemical studies of angiogenic cytokines and their receptors in myelofibrosis with myeloid metaplasia

被引:34
作者
Chou, JM
Li, CY
Tefferi, A
机构
[1] Mayo Clin & Mayo Fdn, Div Hematol & Internal Med, Rochester, MN 55905 USA
[2] Tri Serv Gen Hosp, Natl Def Med Ctr, Dept Pathol, Div Hematopathol, Taipei, Taiwan
[3] Mayo Clin & Mayo Fdn, Div Hematopathol, Rochester, MN 55905 USA
关键词
basic fibroblast growth factor; bone marrow; cytokine; immunohistochemistry; myelofibrosis; platelet-derived growth factor; transforming growth factor; vascular endothelial growth factor;
D O I
10.1016/S0145-2126(02)00268-0
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Bone marrow specimens from I I patients with myelofibrosis with myeloid metaplasia (MMM) and seven normal controls were studied immumohistochemically to determine expression of transforming growth factor beta(TGF-beta), platelet-derived growth factor (PDGF), vascular endothelial growth factor (VEGF), basic fibroblast growth factor (bFGF) and corresponding receptors. Staining distribution and intensity for TGF-beta, PDGF, VEGF, TGF-beta type II receptor, a receptor for PDGF, and receptors for VEGF and bFGF were similar in patients and controls. Bone marrow from 10 MMM patients showed increased TGF-beta type I receptor (TGF-betaRI) expression in small vessel endothelial cells. Eight patient specimens had bFGF overexpression in megakaryocytes. Increased microvessel density and decreased concentration of bFGF-staining stromal cells accompanied these changes. Microvascular TGF-betaRI upregulation and bFGF overexpression by megakaryocytes may cause bone marrow microenvironmental changes in MMM patients. (C) 2003 Elsevier Science Ltd. All rights reserved.
引用
收藏
页码:499 / 504
页数:6
相关论文
共 48 条
  • [1] Amizuka N, 1998, MICROSC RES TECHNIQ, V41, P313
  • [2] Myeloablation and autologous peripheral blood stem cell rescue results in hematologic and clinical responses in patients with myeloid metaplasia with myelofibrosis
    Anderson, JE
    Tefferi, A
    Craig, F
    Holmberg, L
    Chauncey, T
    Appelbaum, FR
    Guardiola, P
    Callander, N
    Freytes, C
    Gazitt, Y
    Razvillas, B
    Deeg, HJ
    [J]. BLOOD, 2001, 98 (03) : 586 - 593
  • [3] Vascular development: Cellular and molecular regulation
    Beck, L
    DAmore, PA
    [J]. FASEB JOURNAL, 1997, 11 (05) : 365 - 373
  • [4] Angiogenesis in cancer and other diseases
    Carmeliet, P
    Jain, RK
    [J]. NATURE, 2000, 407 (6801) : 249 - 257
  • [5] Chen QS, 1999, INT J HEMATOL, V70, P155
  • [6] Pioneer axon guidance by UNC-129, a C-elegans TGF-β
    Colavita, A
    Krishna, S
    Zheng, H
    Padgett, RW
    Culotti, JG
    [J]. SCIENCE, 1998, 281 (5377) : 706 - 709
  • [7] Of worms and men: An evolutionary perspective on the fibroblast growth factor (FGF) and FGF receptor families
    Coulier, F
    Pontarotti, P
    Roubin, R
    Hartung, H
    Goldfarb, M
    Birnbaum, D
    [J]. JOURNAL OF MOLECULAR EVOLUTION, 1997, 44 (01) : 43 - 56
  • [8] Investigation of calmodulin and basic fibroblast growth factor (bFGF) in idiopathic myelofibrosis: Evidence for a role of extracellular calmodulin in fibroblast proliferation
    Dalley, A
    Smith, JM
    Reilly, JT
    MacNeil, S
    [J]. BRITISH JOURNAL OF HAEMATOLOGY, 1996, 93 (04) : 856 - 862
  • [9] THALIDOMIDE IS AN INHIBITOR OF ANGIOGENESIS
    DAMATO, RJ
    LOUGHNAN, MS
    FLYNN, E
    FOLKMAN, J
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1994, 91 (09) : 4082 - 4085
  • [10] DICKSON MC, 1995, DEVELOPMENT, V121, P1845